21st Century Cures Offers More Latitude to Promote Health Care Economic Information, but Ambiguities Would Remain
Original Article Featured on Hogan Lovells
Last Wednesday, the U.S. House of Representatives passed the 21st Century Cures Act , the culmination of an extensive, multi-year effort by the House Energy and Commerce Committee to develop this sweeping legislation. The 21st Century Cures Act now faces a vote in the Senate, likely within days. The White House has already expressed support for the bill, so assuming it passes in the Senate, it is very likely to become law. Among the numerous provisions of this voluminous bill, Section 3037 expands the permissible scope of drug manufacturers’ promotion of health care economic information (HCEI).